Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iniparib Treatment Extension Study
NCT01593228Phase 3Completed
- Sponsor
- Sanofi
- Start
- May 2012
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of iniparib in solid tumor, sponsored by Sanofi. Started May 2012; status: completed.
02
Drugs
iniparib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT01593228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01593228.